journal article·2022-07-28

Probing Molecular Packing of Drug Substances in Nanometer Domains in Pharmaceutical Formulations Using 19F Magic Angle Spinning NMR

Pyae Phyo, Wei Xu, Derek Frank, Tonglei Li, Yongchao Su

The Journal of Physical Chemistry C· Volume 126· Issue 29
Publisher page

Abstract

Structural details of molecular packing provide a fundamental understanding of the resulting material properties of pharmaceutical materials. For example, both the physical stability and dissolution rate of amorphous drugs are significantly enhanced by embedding into a polymeric network to form an amorphous solid dispersion. Despite the ubiquitous use of amorphous solid dispersions to formulate poorly water-soluble drugs, structural details elucidating the molecular mechanism of drug recrystallization remain elusive. In this study, solid-state NMR was used to quantitatively determine the size of the drug-rich domains in amorphous solid dispersions and determine the number of drug molecules within the polymer matrix by using 19 F centerband-only detection of exchange (CODEX). Such results provide the highest resolution of oligomeric packing of drug molecules in the nanometer domain in an amorphous dispersion and offer a valuable structural basis for how drug–drug interaction induces recrystallization in a confined polymer matrix.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced NMR Techniques and Applications · NMR spectroscopy and applications · Advanced MRI Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States

Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States

Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States

References (64)

Show source-provided references
1. 10.1016/j.ijpharm.2020.11956010.1016/j.ijpharm.2020.119560 ↗
2. 10.1016/j.apsb.2021.05.01410.1016/j.apsb.2021.05.014 ↗
3. 10.1016/j.ddtec.2011.10.00210.1016/j.ddtec.2011.10.002 ↗
4. 10.1002/jps.2207410.1002/jps.22074 ↗
5. 10.1002/jps.2335810.1002/jps.23358 ↗
6. 10.1021/mp500514610.1021/mp5005146 ↗
7. 10.1021/acs.molpharmaceut.6b0074010.1021/acs.molpharmaceut.6b00740 ↗
8. 10.1021/acs.molpharmaceut.8b0021910.1021/acs.molpharmaceut.8b00219 ↗
9. 10.1021/acs.molpharmaceut.6b0080310.1021/acs.molpharmaceut.6b00803 ↗
10. 10.1021/acs.molpharmaceut.9b0127210.1021/acs.molpharmaceut.9b01272 ↗
11. 10.1007/s11095-016-1969-210.1007/s11095-016-1969-2 ↗
12. 10.1021/acs.molpharmaceut.0c0059210.1021/acs.molpharmaceut.0c00592 ↗
13. 10.1016/j.jpba.2017.07.06610.1016/j.jpba.2017.07.066 ↗
14. 10.1016/j.ijpharm.2018.07.02910.1016/j.ijpharm.2018.07.029 ↗
15. 10.1021/acs.molpharmaceut.5b0092510.1021/acs.molpharmaceut.5b00925 ↗
16. 10.1016/j.trac.2020.11615210.1016/j.trac.2020.116152 ↗
17. 10.1007/s11095-017-2145-z10.1007/s11095-017-2145-z ↗
18. 10.1016/j.ijpharm.2018.11.06710.1016/j.ijpharm.2018.11.067 ↗
19. 10.1016/j.ijpharm.2018.07.02910.1016/j.ijpharm.2018.07.029 ↗
20. 10.1021/mp100205g10.1021/mp100205g ↗
21. 10.1021/mp400498n10.1021/mp400498n ↗
22. 10.1016/j.jddst.2019.01.01710.1016/j.jddst.2019.01.017 ↗
23. 10.1002/jps.2173810.1002/jps.21738 ↗
24. 10.1021/mp500829v10.1021/mp500829v ↗
25. 10.1021/acs.molpharmaceut.5b0070510.1021/acs.molpharmaceut.5b00705 ↗
26. 10.1021/acs.molpharmaceut.5b0033310.1021/acs.molpharmaceut.5b00333 ↗
27. 10.1021/mp500692a10.1021/mp500692a ↗
28. 10.1021/mp400495h10.1021/mp400495h ↗
29. 10.1021/acs.molpharmaceut.9b0030110.1021/acs.molpharmaceut.9b00301 ↗
30. 10.1016/j.jpba.2018.11.00110.1016/j.jpba.2018.11.001 ↗
31. 10.1002/mrc.126024090710.1002/mrc.1260240907 ↗
32. 10.1016/0378-5173(94)00208-M10.1016/0378-5173(94)00208-M ↗
33. 10.1016/S0939-6411(97)00118-510.1016/S0939-6411(97)00118-5 ↗
34. 10.1021/acs.molpharmaceut.9b0017410.1021/acs.molpharmaceut.9b00174 ↗
35. 10.1039/D0CP02049D10.1039/D0CP02049D ↗
36. 10.1021/acs.molpharmaceut.0c0026810.1021/acs.molpharmaceut.0c00268 ↗
37. 10.1063/1.497482910.1063/1.4974829 ↗
38. 10.1021/acs.jpcb.0c0213110.1021/acs.jpcb.0c02131 ↗
39. Schmidt-Rohr K. · Encyclopedia of Nuclear Magnetic Resonance · 2007 · 9 · 633
40. 10.1021/ja992022v10.1021/ja992022v ↗
41. 10.1021/ja060340610.1021/ja0603406 ↗
42. 10.1021/acs.molpharmaceut.9b0017410.1021/acs.molpharmaceut.9b00174 ↗
43. 10.1021/acs.jpcb.8b0031010.1021/acs.jpcb.8b00310 ↗
44. 10.1007/BF0226534910.1007/BF02265349 ↗
45. 10.1007/s11095-006-9086-210.1007/s11095-006-9086-2 ↗
46. 10.1016/j.jpba.2017.07.06610.1016/j.jpba.2017.07.066 ↗
47. 10.1002/actp.1993.01044010110.1002/actp.1993.010440101 ↗
48. 10.1021/jp073823k10.1021/jp073823k ↗
49. 10.1016/j.bpj.2016.09.04810.1016/j.bpj.2016.09.048 ↗
50. 10.1006/jmre.2001.235110.1006/jmre.2001.2351 ↗
51. 10.1016/j.jmb.2017.05.01510.1016/j.jmb.2017.05.015 ↗
52. 10.1016/j.bpj.2013.02.05410.1016/j.bpj.2013.02.054 ↗
53. 10.1021/bi900080d10.1021/bi900080d ↗
54. 10.1021/acs.analchem.1c0078410.1021/acs.analchem.1c00784 ↗
55. 10.1021/acs.analchem.1c0291710.1021/acs.analchem.1c02917 ↗
56. 10.1021/acs.analchem.9b0088410.1021/acs.analchem.9b00884 ↗
57. 10.1021/jacs.1c1205610.1021/jacs.1c12056 ↗
58. 10.1021/cg300370q10.1021/cg300370q ↗
59. 10.1021/acs.cgd.0c0031210.1021/acs.cgd.0c00312 ↗
60. 10.1002/anie.20190765210.1002/anie.201907652 ↗
61. 10.1002/cphc.20200051710.1002/cphc.202000517 ↗
62. 10.1021/ja00363a06010.1021/ja00363a060 ↗
63. 10.1021/ja00329a05210.1021/ja00329a052 ↗
64. 10.1016/j.jmr.2012.05.01910.1016/j.jmr.2012.05.019 ↗